180 Life Sciences Announces Closing of Private Offering of Approximately $156 Million of Convertible Notes

Stock Information for Tempest Therapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Tempest Therapeutics Inc.

180 Life Sciences (ETHZilla) Holds 82,186 ETH
180 Life Sciences Closes $425 Million Private Placement to Advance its Ethereum Treasury Strategy
180 Life Sciences Announce an Upsized $425 Million Private Placement to Establish an Ether Treasury Reserve Led by Consortium of Digital Asset Leaders to Launch ETHZilla
180 Life Sciences Corp. Announces Strengthening of Legacy Intellectual Property Assets
180 Life Sciences Corp. Announces Notice of Allowance for U.S. Patent Covering Novel Method to Prevent or Reduce Post-Operative Cognitive Dysfunction
180 Life Sciences Corp. Announces Share Repurchase
180 Life Sciences Corp. Announces Pricing of $2.9 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under NASDAQ Rules
180 Life Sciences Corp. Regains Full Compliance with Nasdaq Continued Listing Rules

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.